IRIS
DI STEFANO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.086
EU - Europa 4.939
AS - Asia 1.744
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 9
AF - Africa 4
Totale 11.792
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.061
IT - Italia 1.144
CN - Cina 926
IE - Irlanda 856
UA - Ucraina 778
SE - Svezia 606
GB - Regno Unito 565
TR - Turchia 528
FR - Francia 461
DE - Germania 260
IN - India 218
FI - Finlandia 147
BE - Belgio 29
VN - Vietnam 28
CA - Canada 22
IR - Iran 19
AT - Austria 17
HK - Hong Kong 16
PL - Polonia 13
ES - Italia 12
GR - Grecia 11
RU - Federazione Russa 11
EU - Europa 10
BR - Brasile 5
CH - Svizzera 5
RO - Romania 4
NL - Olanda 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AR - Argentina 2
CL - Cile 2
CZ - Repubblica Ceca 2
HU - Ungheria 2
KR - Corea 2
NO - Norvegia 2
PA - Panama 2
TN - Tunisia 2
BG - Bulgaria 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
JP - Giappone 1
ME - Montenegro 1
MM - Myanmar 1
MT - Malta 1
MX - Messico 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 11.792
Salva come PNG Salva come JPEG
Città #
Chandler 1.123
Jacksonville 928
Dublin 844
Southend 460
Princeton 373
Chieti 327
Izmir 298
Nanjing 265
Ashburn 229
Dearborn 228
Ann Arbor 200
Wilmington 175
Cambridge 146
Altamura 143
Beijing 122
Nanchang 95
New York 83
Boardman 79
Shenyang 67
Woodbridge 53
Tianjin 52
Hebei 48
Kunming 47
Washington 42
Pescara 32
Jinan 30
Brussels 29
Grevenbroich 29
Kocaeli 29
Dong Ket 28
Falls Church 26
Jiaxing 26
Leawood 25
Zhengzhou 23
Los Angeles 21
Hangzhou 20
Houston 20
San Mateo 20
Augusta 19
Norwalk 19
Rome 19
Seattle 19
Ningbo 18
Milan 17
Changsha 16
Vienna 16
Lanciano 15
Ardabil 14
Auburn Hills 14
Lanzhou 14
Silvi 14
Guangzhou 13
Teramo 13
Bologna 12
Hong Kong 12
Kraków 12
Helsinki 11
Orange 11
Düsseldorf 10
Isernia 10
L'aquila 10
Orsogna 10
Santa Maria Imbaro 10
Simi Valley 10
Changchun 9
Taizhou 9
Monmouth Junction 8
Bari 7
Campomarino 7
Edinburgh 7
Hefei 7
San Jose 7
Catania 6
Erzurum 6
Laval 6
Serra 6
Tappahannock 6
Ancona 5
Bonn 5
Haikou 5
Nashville 5
Pune 5
Sacramento 5
Toronto 5
Cedar Knolls 4
Cepagatti 4
Circello 4
Fairfield 4
Ferrara 4
Kowloon 4
Marche 4
Mumbai 4
Naples 4
Perugia 4
Redwood City 4
San Donato Milanese 4
Sesena Nuevo 4
Tolentino 4
Andover 3
Bangalore 3
Totale 7.331
Salva come PNG Salva come JPEG
Nome #
Viscoelastic properties of Staphylococcus aureus and Staphylococcus epidermidis mono-microbial biofilms 154
Development of glycine-α-methyl-proline-containing tripeptides with neuroprotective properties 122
Gold nanoparticles as scaffolds for poor water soluble and difficult to vehiculate antiparkinson codrugs 117
Sintesi e valutazione dell’attività antimicrobica di nuovi carvacrolo codrugs 116
Synthesis of a novel cyclic prodrug of S -allyl-glutathione able to attenuate LPS-induced ROS production through the inhibition of MAPK pathways in U937 cells 113
Chelating and antioxidant properties of l-Dopa containing tetrapeptide for the treatment of neurodegenerative diseases 109
Modulation of apoptotic cell death and neuroprotective effects of glutathione—L-Dopa codrug against H2O2-induced cellular toxicity 106
Preparation and characterization of polymeric micelles loaded with a potential anticancer prodrug 104
NSAID Coniugates for the treatment of Alzheimer's Disease 104
Single-Walled Carbon Nanotubes in Highly Viscous Media: A Comparison between the Dispersive Agents [BMIM][BF4], L121, and Triton X-100 100
Synthesis and evaluation of trans-2-amino-5(or 6)-chloro-6(or 5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 99
Synthesis of a novel TRH-related sulphonamido peptide 99
(R)-α-Lipoyl-Gly-L-Pro-L-Glu dimethyl ester as dual acting agent for the treatment of Alzheimer's disease 98
Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization 96
Sintesi di trans-2-ammino-5(o 6)-cloro-6(o 5)-idrossi-1-fenil-2,3-diidro-1H-indani quali precursori di derivati a potenziale affinità per i recettori della dopamina 93
Cofarmaci L-Dopa-antiossidanti solforati quali nuovi potenziali agenti anti-Parkinson 93
(R)-α-Lipoyl-glycyl-L-prolyl-L-glutamyl dimethyl ester codrug as a multifunctional agent with potential neuroprotective activities 93
Zingiberene attenuates hydrogen peroxide-induced toxicity in neuronal cells 92
Characterization of alkanoyl-10-O-minocyclines in micellar dispersions as potential agents for treatment of human neurodegenerative disorders 91
Carvacrol prodrugs as novel antimicrobial agents 90
A glutathione derivative with chelating and in vitro neuroprotective activities: synthesis, physicochemical properties, and biological evaluation. 89
Preparation of boronate derivatives for the treatment of diseases and conditions associated to oxidative stress 89
Toxicity assessment of hydroxyapatite nanoparticles in rat liver cell model in vitro 88
Health risk assessments of lithium titanate nanoparticles in rat liver cell model for its safe applications in nanopharmacology and nanomedicine 87
Synthesis and preliminary pharmacological evaluation of 2,3,4,8,13a-hexahydro-1H-benzo(5,6)cyclohepta(1,2,3-ef)(3)benzazepine-6,7-diol derivatives as dopamine receptor ligands 85
Sintesi di trans-2-ammino-1-fenil-5-fluoro-6-idrossi (e 6-fluoro-5-idrossi)-2,3-diidro-1H-indeni quali potenziali ligandi per i recettori dopaminergici 85
A novel TRH analog containing a gamma-sultam residue replacing the pyroglutamic acid 85
L-dopa co-drugs in nanostructured lipid carriers: A comparative study 85
Synthesis and preliminary evaluation of L-dopa/benserazide conjugates as dual acting codrugs 85
Synthesis and Study of L-Dopa-Glutathione Codrugs as New Anti-Parkinson Agents with Free Radical Scavenging Properties. 84
Synthesis and biological evaluation of novel analogues of Gly-l-Pro-l-Glu (GPE) as neuroprotective agents 83
“Evaluation of endocrine disruptors, TPHPand DPHP, effect on DNA repair damage pathwais in a normal human thyroid cell model” 83
Carvacrol codrugs: A new approach in the antimicrobial plan 83
Synthesis and antioxidant properties of novel memantine derivatives 83
Gold nanoparticles as scaffolds for new antiparkinson prodrugs 82
Novel hydrogel and functionalized silica for dispersion of CO2 and carbon nanotube-based catalysts 82
Carvacrol and its derivatives as antibacterial agents 82
Antiparkinson Prodrugs 82
Synthesis and preliminary pharmacological evaluation of trans-2-amino-5(6)-chloro-6(5)-hydroxy-1- phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 81
sintesi ed attività di due analoghi del glutatione a conformazione ristretta 81
Biodegradable microspheres loaded with an antiparkinson prodrug: an in vivo pharmacokinetic study 81
Novel NSAID-derived drugs for the potential treatment of Alzheimer’s disease 81
Synthesis and Biological Evaluation of Novel Selenyl and Sulfur-l-Dopa Derivatives as Potential Anti-Parkinson's Disease Agents 81
Potential Antibacterial Activity of Carvacrol-Loaded PLGA Nanoparticles against Microbial Biofilm 81
Synthesis of a novel glutathione analogue as potential inhibitor of glutathione-S-transferase 80
Synthesis and preliminary pharmacological evaluation of 5-hydroxy and 5,6-dihydroxy-benzo(5,6)cyclohept(1,2,3-ij)isoquinoline derivatives as dopamine receptor ligands 80
Design, synthesis and preliminary pharmacological evaluation of new imidazolinones as L-DOPA prodrugs. 80
Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating Alzheimer's disease 80
Temporal expression of agrB, cidA and alsS in the early development of Staphylococcus aureus UAMS-1 biofilm formation and the structural role of extracellular DNA and carbohydrates 80
Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy-2,3, 12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinolines as dopamine receptor ligands. 79
Effect of MRJF4 on C6 glioma cells proliferation and migration 79
Direct- and spacer-coupled codrug strategies for the treatment of Alzheimer’s disease 78
Twin amides as potential prodrugs of L-DOPA 78
Memantine-derived drugs as potential antitumor agents for the treatment of glioblastoma 78
Advances in prodrug design for Parkinson's disease 78
Ibuprofen and lipoic acid diamide as co-drugs with neuroprotective activity: pharmacological properties and effects in β-amyloid (1-40) infused Alzheimer’s disease rat model. 77
Memantine-sulphur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer’s disease 77
Synthesis of l-(+)-3-(3-hydroxy-4-pivaloyloxybenzyl)-2,5-diketomorpholine as potential prodrug of l-dopa 77
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 77
CNS delivery of L-Dopa by a new Hybrid Glutathione-Methionine peptidomimetic prodrug 76
HPLC–FLD and spectrofluorometer apparatus: How to best detect fluorescent probe-loaded niosomes in biological samples 76
Role of Dietary Supplements in the Management of Parkinson's Disease 76
Transition state isosteres of the gamma-glutamyl peptide bond hydrolysis: synthesis and characterization of the psi (CH2NH) pseudopeptide analogue of glutathione 76
Evaluation of 2,3,4,8,13a hexahydro-1H-Benzo[5,6]cyclohepta-6,7-dihydroxy[1,2,3-ef][3]benzazepine derivatives as dopamine receptor ligands 75
New drug delivery strategies for improved Parkinson’s disease therapy 75
Synthesis and evalutation of 2-(5-methoxythiophen-3-yl)ethylamines as potential dopamine agonists 74
In vitro evaluation of the potential anticancer activity of new memantin co-drugs on rat C6 glioblastoma cells 74
RNAIII Inhibiting Peptide (RIP) and derivatives as potential tools for the treatment of S. aureus biofilm infections 74
synthesis and biological evaluation as anti-Parkinson agent of an analogue of Glutathione-L-Dopa containing methionine in place of the cysteinil residue 73
Synthesis and evalutation of N-n-propyl-N-(2-phenylethyl)-2-(3-fluoro-4-hydroxy-phenyl) ethylamine derivatives 72
Evaluation of rat striatal L-Dopa and DA concentration after intraperitoneal administration of L- Dopa prodrugs in liposomal formulations 72
Toll-like receptor-2 agonist functionalized biopolymer for mucosal vaccination 72
Codrugs Linking l-Dopa and Sulfur-Containing Antioxidants: New Pharmacological Tools against Parkinson’s Disease 72
synthesis and Activity of L-Dopa-Thiol antioxidant Co-drugs and New anti-PArkinson Agents with free Radical Scavenging Properties 72
Transdermal donepezil on the treatment of Alzheimer’s disease 72
Preparation and pharmacological characterization of trans-2-amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like dopamine receptor agonists 72
Novel hydrogels for dispersion of carbon nanotube-based catalysts 71
Evidence for a Dopamine Intrinsic Direct Role in the Regulation of the Ovary Reproductive Function: In Vitro Study on Rabbit Corpora Lutea 71
Glycosyl and polyalcoholic prodrugs of lonidamine 70
Design and synthesis of multifunctional drugs: a strategy to improve the treatment of Parkinson’s disease 70
L-Dopa Prodrugs: An Overview of Trends for Improving Parkinson's Disease Treatment 70
MRJF4, a novel histone deacetylase inhibitor, induces p21 mediated autophagy in PC3 prostate cancer cells 70
Nuovi S-coniugati del glutatione ad attività inibitoria nei confronti delle GST umane 69
Detection of levodopa, dopamine and its metabolites in rat striatum dialysates following peripheral administration of L-DOPA prodrugs by mean of HPLC-EC 69
Synthesis and activity of novel glutathione analogues containing an urethane backbone linkage 69
Ibuprofen and lipoic acid diamides as potential codrugs with neuroprotective activity 69
NOS-mediated morphological and molecular modifications in rats infused with Aβ (1-40), as a model of Alzheimer’s Disease, in response to a new lipophilic molecular combination codrug-1 69
Benzimidazole, benzoxazole and benzothiazole derivatives as 5HT2B receptor ligands. Synthesis and preliminary pharmacological evaluation 68
Maleic- and Fumaric-diamides of (O,O-diacetyl)-L-Dopa-methylester as anti-Parkinson prodrugs in liposomal formulation 68
Stimulation of Human Macrophages (THP-1) using Toll-like Receptor-2 (TLR-2) Agonist Decorated Nanocarriers 68
Prodrug approach for increasing cellular glutathione levels 68
Drug Delivery Strategies for Alzheimer's Disease Treatment 68
Surfactant Hydrogels for the Dispersion of Carbon-Nanotube-Based Catalysts 68
Natural oxyprenylated coumarins are modulators of melanogenesis 68
Potent isozyme-selective inhibition of human glutathione S-transferase A1-1 by a novel glutathione S-conjugate 68
Synthesis and biological evaluation of the disulfide form of the glutathione analogue gamma-(L-glutamyl)-L-cysteinyl-L-aspartyl-L-cysteine. 67
Designing Prodrugs for the Treatment of Parkinson's Disease 67
Au nanoparticles functionalized by newly synthetised antiparkinson prodrugs 67
Nanoencapsulation strategies for the delivery of novel bifunctional antioxidant/σ1 selective ligands 67
Synthesis and biological evaluation of a novel pyroglutamil-modified TRH analogue 66
Totale 8.173
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.223
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.223
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019418 0 0 0 0 0 0 0 0 0 0 18 400
2019/20202.405 687 147 27 78 181 215 342 205 66 206 207 44
2020/20211.198 166 13 183 27 87 214 31 24 92 151 136 74
2021/2022918 33 32 13 94 93 33 34 61 131 42 89 263
2022/20233.067 235 464 178 332 280 584 153 281 367 47 66 80
2023/20241.309 99 82 102 54 94 461 318 55 20 24 0 0
Totale 12.342